DINAK-004

N/A

Report date: 2024/09/02 15:39:38

Base Information

Drug NameDINAK-004

Drug Alias NameDINAK-004

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionGene transference

TargetsUpdating

Therapy Area/IndicationsNephrotic Syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDinaqor AG

China Registration ClassN/A

Active CompaniesDinaqor AG

Inactive CompaniesN/A

Active IndicationsNephrotic Syndrome

Inactive IndicationsN/A

ATC CodeN/A